SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-14-076630
Filing Date
2014-12-31
Accepted
2014-12-31 16:30:52
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 v396806_s3.htm S-3 268208
2 EXHIBIT 4.6 v396806_ex4-6.htm EX-4.6 493760
3 EXHIBIT 5.1 v396806_ex5-1.htm EX-5.1 35523
4 EXHIBIT 12.1 v396806_ex12-1.htm EX-12.1 9278
5 EXHIBIT 23.1 v396806_ex23-1.htm EX-23.1 2404
6 GRAPHIC tlogo.jpg GRAPHIC 13816
7 GRAPHIC tlogo1.jpg GRAPHIC 4206
8 GRAPHIC tlogo_alston.jpg GRAPHIC 6846
  Complete submission text file 0001144204-14-076630.txt   845105
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-201339 | Film No.: 141318874
SIC: 2834 Pharmaceutical Preparations